Here's the live share price of Alkem Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Alkem Laboratories | 2.41 | -2.72 | -8.26 | -2.08 | 10.32 | 17.33 | 14.42 |
| Sun Pharmaceutical Industries | -2.42 | -9.38 | -4.79 | -0.89 | -2.01 | 17.90 | 21.71 |
| Divi's Laboratories | 3.16 | -4.84 | -6.88 | -7.81 | 8.03 | 27.39 | 9.85 |
| Torrent Pharmaceuticals | 5.27 | -5.19 | 6.36 | 19.31 | 34.27 | 39.27 | 26.91 |
| Lupin | 1.96 | -1.02 | 6.02 | 17.82 | 17.90 | 52.05 | 17.29 |
| Dr. Reddy's Laboratories | 0.29 | -7.88 | 0.45 | -3.24 | 10.09 | 8.61 | 4.12 |
| Cipla | 1.60 | -8.82 | -17.29 | -22.47 | -17.13 | 10.14 | 6.06 |
| Zydus Lifesciences | 6.80 | 0.11 | 3.13 | -7.10 | 6.31 | 22.65 | 13.07 |
| Mankind Pharma | 4.66 | -6.82 | -6.13 | -14.39 | -11.09 | 13.61 | 7.95 |
| Aurobindo Pharma | 0.63 | 3.04 | 14.64 | 18.26 | 24.18 | 35.30 | 7.97 |
| Glenmark Pharmaceuticals | 3.47 | -4.64 | 7.37 | 13.39 | 57.30 | 64.65 | 34.16 |
| Laurus Labs | 4.10 | 4.50 | 4.29 | 24.11 | 79.34 | 53.19 | 21.18 |
| Biocon | -3.02 | -13.52 | -8.10 | -2.12 | 8.01 | 16.59 | -3.27 |
| Abbott India | -1.81 | -5.19 | -9.20 | -13.89 | -12.77 | 4.38 | 11.44 |
| Anthem Biosciences | 11.37 | 13.56 | 19.24 | -6.17 | 0.83 | 0.28 | 0.17 |
| GlaxoSmithKline Pharmaceuticals | 5.43 | -1.98 | 1.55 | -11.46 | -11.33 | 23.86 | 10.87 |
| Ipca Laboratories | -2.40 | -5.34 | -5.10 | 9.63 | 8.91 | 20.66 | 6.23 |
| Ajanta Pharma | 3.44 | -5.06 | 5.75 | 19.59 | 12.64 | 31.11 | 20.44 |
| J B Chemicals & Pharmaceuticals | 3.56 | -4.64 | 7.96 | 21.87 | 28.68 | 26.00 | 27.19 |
| Emcure Pharmaceuticals | 5.08 | 4.21 | 8.55 | 18.82 | 77.10 | 6.23 | 3.69 |
Over the last one year, Alkem Laboratories has gained 10.32% compared to peers like Sun Pharmaceutical Industries (-2.01%), Divi's Laboratories (8.03%), Torrent Pharmaceuticals (34.27%). From a 5 year perspective, Alkem Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (21.71%) and Divi's Laboratories (9.85%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 5,239.31 | 5,333.87 |
| 10 | 5,267.66 | 5,312.75 |
| 20 | 5,343.74 | 5,340.49 |
| 50 | 5,509.35 | 5,441.41 |
| 100 | 5,586.27 | 5,485.57 |
| 200 | 5,409.49 | 5,438.07 |
In the latest quarter, Alkem Laboratories remained same as its previous close in promoter holding, while DII stake decreased to 21.54%, FII holding rose to 9.97%, and public shareholding moved down to 17.30% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 28,32,306 | 1.69 | 1,597.28 | |
| 13,84,266 | 0.94 | 780.66 | |
| 10,42,327 | 2.06 | 587.82 | |
| 4,18,259 | 3.47 | 235.88 | |
| 3,95,378 | 0.94 | 222.97 | |
| 3,92,688 | 1.13 | 221.46 | |
| 3,12,441 | 0.62 | 176.2 | |
| 2,75,425 | 1.17 | 155.33 | |
| 2,50,713 | 0.99 | 141.39 | |
| 2,50,000 | 2.05 | 140.99 |
* Excluding Index & Arbitrage Funds
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Date Time | Announcement |
|---|---|
| Apr 07, 2026, 09:01 PM IST IST | Alkem Laboratories - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Apr 02, 2026, 06:34 PM IST IST | Alkem Laboratories - Please Find Attached Herewith Intimation About Increase In Investment To Be Made For Setting Up Of Manuf |
| Apr 01, 2026, 12:18 AM IST IST | Alkem Laboratories - Announcement under Regulation 30 (LODR)-Change in Management |
| Mar 30, 2026, 11:15 PM IST IST | Alkem Laboratories - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 20 |
| Mar 27, 2026, 11:46 PM IST IST | Alkem Laboratories - Announcement under Regulation 30 (LODR)-Change in Management |
Alkem Laboratories Ltd. is a Public Limited Listed company incorporated on 08/08/1973 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L00305MH1973PLC174201 and registration number is 174201. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 8813.44 Cr. and Equity Capital is Rs. 23.91 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Alkem Laboratories is ₹5,366.60 as on Apr 13, 2026.
The Alkem Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Alkem Laboratories is ₹64,373.20 Cr as on Apr 13, 2026.
Today’s highest and lowest price of Alkem Laboratories are ₹5,424.00 and ₹5,290.60.
The 52-week high/low is the highest and lowest price at which Alkem Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Alkem Laboratories is ₹5,933.00 and 52-week low of Alkem Laboratories is ₹4,716.75 as on Apr 13, 2026.
The Alkem Laboratories has shown returns of -1.31% over the past day, -2.99% for the past month, -8.51% over 3 months, 10.01% over 1 year, 17.23% across 3 years, and 14.36% over 5 years.
P/E ratio of and PB ratio of Alkem Laboratories are 27.15 and 4.60 on Apr 13, 2026. While the company gives a dividend yield of 0.84 per annum.